Evaluation of Serum CTNNβ1 and E-cadherin Levels in Hepatitis Patients
Journal Title: Viral Hepatitis Journal - Year 2020, Vol 26, Issue 3
Abstract
Objectives: Hepatitis B virus (HBV) infection is one of the leading causes of hepatocellular carcinoma, but the underlying molecular mechanisms are quite complex. In this study, the aim was to reveal the relationship of these parameters with HBV-DNA loads by evaluating serum CTNNβ1 (β-catenin) and E-cadherin levels in hepatitis B patients. Materials and Methods: In this study, between the dates of June 15.06.2018-December 30.12.2019, 75 people who were diagnosed with chronic hepatitis B constituted the patient group (n=75), and 75 people who were not diagnosed with chronic hepatitis B constituted the healthy control group (n=75). In this retrospective study using a random sampling method, the hepatitis B patient group was classified into 3 separate groups among themselves according to HBV-DNA loads; HBV-DNA-1 (x106-108, n=25), HBV-DNA-2 (x103-104, n=25) and HBV-DNA-3 (x101-102, n=25). While the level of serum β-catenin and E-cadherin, the main parameters in the study, were measured using the ELISA method with a commercial kit, the Chemiluminescent Microparticle Immunoassay method was used to evaluate the serological markers in the patients. HBV-DNA level was determined by real-time polymerase chain reaction. Results: In our study, the average age of individuals was 41.96±13.86 years in the control group and 36.72±16.3, 42.8±10.91 and 46.36 ±12.58 years in the HBV-DNA-1, 2, and 3 groups, respectively. The low age in the HBV-DNA-1 group compared to other groups was statistically significant (p=0.001; p<0.01). The values of E-cadherin were 44.57±29.61 ng/mL in the control group, and 42.76±23.23, 45.72±27.33 and 71.02±31.03 ng/mL in HBV-DNA-1, 2 and 3 groups, respectively. In addition, E-cadherin values were statistically significant in the HBV-DNA-3 group compared to other groups (p=0.001; p<0.01). The values of β-catenin were 0.75±0.47 ng/mL in the control group and were 1.05±0.63, 0.93±0.4 and 1.58±1.94 ng/mL in the DNA-1, 2, and 3 groups, respectively. The β-catenin value in the control group was found to be statistically significant compared to hepatitis B groups (p=0.001; p<0.01). Conclusion: E-cadherin values were found to be significantly lower in the HBV-DNA-1 group with the highest viral load. There may be a loss of E-cadherin due to severe inflammation in this group. Monitoring the levels of β-catenin and E-cadherin may be important for evaluating the possible risk and prognosis for liver carcinoma in these patients.
Authors and Affiliations
Arzu Şahin, Yeliz Çetinkol, Selma Cırrık, Mustafa Kerem Çalgın, Tevfik Noyan, Numan Taşpınar
Keywords
Related Articles
- EP ID EP691647
- DOI 10.4274/vhd.galenos.2020.2020.0026
- Views 101
- Downloads 0
Evaluation of Health-Related Life Quality of Patients with Chronic Hepatitis Admitted to a Medical Faculty Hospital
Objectives: The aim of this study was to determine the life quality and related factors of patients with chronic hepatitis B and C who admitted to the Infectious Diseases Clinic of Erciyes University Medical Faculty Hosp...
A Comparison of Needle Types and Biopsy Techniques Used in Liver Biopsies of Chronic Hepatitis B Patients
Objectives: To investigate the effect of the biopsy technique used in percutaneous liver biopsies applied with semi-automatic 16 gauge (G) and 18G Tru-cut and Menghini aspiration needles in patients with chronic hepatiti...
Comparison of Qiagen and Iontek Hepatitis B Virus-DNA Polymerase Chain Reaction Quantitation Kits in Chronic Hepatitis B Patients Infected with Hepatitis B Virus Genotype D
Objectives: Hepatitis B virus (HBV)-DNA level is a good marker for viral replication and should be monitored at regular intervals in patients with chronic hepatitis B (CHB). The objective of this study is to compare the...
Investigating Hepatitis C, D and HIV Prevalance in Cases with Positive Hepatitis B Virus Antigen in a Tertiary Hospital and Examining Anti-HDV Positive Cases
Objectives: Hepatitis B infection has a faster and more progressive course in the presence of hepatitis C virus (HCV), HDV and human immunodeficiency virus (HIV) infections. The aim of this study was to determine anti-HC...
The Long-term (10.6 years) Outcome of Hepatitis C patients with Sustained Virologic Response Following Treatment with Pegylated Interferon + Ribavirin
Objectives: Directly-acting anti-viral agents for the treatment of hepatitis C have been revolutionised. In the meantime, hepatitis C patients with sustained virologic response (SVR) achieved with previous treatments hav...